kbp-089
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 17, 2018 (NCT03907202)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Calcitonin receptorAGONIST
CALCR agonist
Amylin receptor AMY1, CALCR/RAMP1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03907202 | Phase 1 | Apr 17, 2018 | Eli Lilly, KeyBioscience AG, Nordic Bioscience, Profil GmbH |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 1 | 0 | 1 | 2018 |
| KeyBioscience AG | For profit | 1 | 1 | 1 | 2018 |
| Nordic Bioscience | For profit | 1 | 0 | 1 | 2018 |
| Profil GmbH | For profit | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1